TP53 and acute promyelocytic leukemia: Our findings also show that CDDP treatment triggered more promyelocytes with dense granules, activated p53 expression, and downregulated MDM2 expression in bone marrow cells (Figure 5A–C) and liver tissues (Figure 6A–D) of APL mice.